欢迎光临源叶生物,登录 | 注册 |
当前位置: 首页 > 小分子化合物 > 小分子抑制剂 > LDN193189 (Hydrochloride)

商品分类

浏览历史

S80068

LDN193189 (Hydrochloride)

MedMol 99%
  • 英文名:
  • LDN193189 (Hydrochloride)
  • 别名:
  • 4-[6-(4-piperazin-1-ylphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline hydrochloride; 3,5-Heptanedione,4-[6-(1,3-benzodioxol-5-yloxy)hexyl]; 4-[6-(3,4-Methylenedioxyphenoxy)hexyl]-3,5-heptanedione;
  • CAS号:
  • 1062368-62-0
  • 分子式:
  • C25H26Cl4N6
  • 分子量:
  • 552.3261
  • 核磁/质谱:
品牌货号产品规格市场价(RMB)您的折扣价(RMB)库存(上海) 北京 武汉 南京 数量计量单位 加入购物车...
MedMol S80068-1mg 99% ¥289.00元 ¥206.00元 7 0 0 0 EA 加入购物车
MedMol S80068-5mg 99% ¥465.00元 ¥465.00元 4 0 0 0 EA 加入购物车
MedMol S80068-10mg 99% ¥1100.00元 ¥578.00元 5 0 0 0 EA 加入购物车
MedMol S80068-25mg 99% ¥2200.00元 ¥935.00元 6 0 0 0 EA 加入购物车
MedMol S80068-50mg 99% ¥3900.00元 ¥1700.00元 预计交期:2-3天 0 0 0 EA 加入购物车
大包装询价

提交您的电话号码并同意《个人信息授权与保护申明》,到货后将短信提示。
提交

产品介绍

参考文献(1篇)

质检证书(COA)

摩尔浓度计算器

相关产品

  • 提示:详情请下载说明书。
  • 产品描述: LDN193189 hydrochloride is a selective BMP type I receptor kinases inhibitor.
  • 靶点: ALK
  • 体外研究: LDN193189 potently inhibits BMP4-mediated Smad1, Smad5 and Smad8 activation with IC50 of 5 nM, and efficiently inhibits transcriptional activity of the BMP type I receptors ALK2 and ALK3 with IC50 of 5 nM and 30 nM, respectively. Furthermore, LDN193189 also shows the inhibitory effect on the transcriptional activity induced by either constitutively active ALK2R206H or ALK2Q207D mutant proteins.A recent study shows that LDN-193189 blocks the production of reactive oxygen species induced by oxidized LDL during atherogenesis in human aortic endothelial cells
  • 体内研究: In conditional caALK2-transgenic mice with Ad.Cre on on postnatal day 7 (P7), LDN-193189 (3 mg/kg i.p) leads to mild calcifications surrounding the left tibia and fibula first visible at P13, and prevents radiographic lesions at P15 without causing weight loss or growth retardation, spontaneous fractures, decreased bone density or behavioral abnormalities.LDN193189 dorsalizes zebrafish embryos by inhibiting signaling pathways induced by bone morphogenetic protein (BMP)6 without effect on vascular development.In PCa-118b tumor-bearing mice, LDN-193189 treatment attenuates tumor growth and reduces bone formation in the tumors.In LDL receptor-deficient (LDLR-/-) mice, LDN-193189 potently inhibits development of atheroma. Moreover, LDN-193189 also exhibits the inhibitory effects on associated vascular inflammation, osteogenic activity, and calcification.
  • 细胞实验: Concentrations: 3 μM
  • 参考文献:
    1. Derwall M, et al. Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis. Arterioscler Thromb Vasc Biol, 2012, 32(3), 613-622. 2. Lee YC, et al. BMP4 promotes prostate tumor growth in bone through osteogenesis. Cancer Res, 2011, 71(15), 5194-5203. 3. Cannon JE, et al. Intersegmental vessel formation in zebrafish: requirement for VEGF but not BMP signalling revealed by selective and non-selective BMP antagonists. Br J Pharmacol, 2010, 161(1), 140-149. 4. Yu PB, et al. BMP type I receptor inhibition reduces heterotopic [corrected] ossification. Nat Med, 2008, 14(12), 1363-1369.
  • 溶解性: soluble  in  DMSO
  • 保存条件: -20℃
  • 配置溶液浓度参考:
    1mg 5mg 10mg
    1 mM 1.811 ml 9.053 ml 18.105 ml
    5 mM 0.362 ml 1.811 ml 3.621 ml
    10 mM 0.181 ml 0.905 ml 1.811 ml
    50 mM 0.036 ml 0.181 ml 0.362 ml
  • 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:


质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子量 (g/mol)


  • =
    *
    *


源叶所有产品仅用作科学研究,销售产品行为均适用于我司网上所列通用销售条款。